4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
MediPharm Labs Corp. (LABS) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Barrie, Canada with about 127 employees. Its market capitalization is roughly C$30 million. In the fiscal year ended 2025-12-31, LABS reported C$45M in revenue and (C$8M) in net income.
MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.
Interactive charts & full statements → Open the LABS valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | C$45M | C$42M | C$33M | C$22M | — |
| Gross Profit | C$14M | C$13M | C$6M | (C$2M) | — |
| Operating Income (EBIT) | (C$8M) | (C$11M) | (C$18M) | (C$29M) | — |
| Net Income | (C$8M) | (C$11M) | (C$13M) | (C$30M) | — |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | C$10M | C$9M | C$11M | C$11M | C$12M | — |
| Gross Profit | C$4M | C$3M | C$4M | C$3M | C$4M | — |
| Operating Income (EBIT) | C$0M | (C$1M) | (C$2M) | (C$2M) | (C$4M) | — |
| Net Income | C$0M | (C$1M) | (C$2M) | (C$2M) | (C$4M) | — |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | C$0M | C$0M | C$0M | C$0M | — |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | C$0M | C$0M | C$0M | C$0M | C$0M | — |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | C$46M | C$54M | C$64M | C$66M | — |
| Total Liabilities | C$10M | C$10M | C$11M | C$10M | — |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LABS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms